Lynn. achieve strong year-over-year for of million. thanks quarter XXXX revenue a We XX% XX.X%. Thanks, increased start. and to joining QX is off first very reaching by growth to margins afternoon, Good X.X points gross $XX.X us.
increase of particularly with driven Our our clinical highlight our adoption with fronts productivity networks. highly sustained some I’d for strategy a additional detailed be proven key growth business our into a to each of increase $XXX $XXX platform strength, the an call expansion as guidance few to which combined catalysts as take Zio remain turn large I’ll has to continues give completeness review hospital XX%. well with many to of by organizational $XXX The platform accounts to service us and the minutes confidence to guidance. $XXX expanding million, like our objectives progress are, million long-term short continues and of our quarter the Zio and over to rates. these from single financial annual our up increased near-term components then market on penetration to Starting the growth our growth contributor salesforce Matt on to with and of our commercial team and addressable our organization, expansion to strengthen XX% our Zio to key sales and new market continued differentiated strategy to annual next indications. our existing and accelerated XXXX of three targeted The superiority. new primary represents revenue that million million improvements,
year, XX we past years, to increasing while sales productivity by of the size reps. most reps channel increased per tenured the the our our of quality successfully have several XX Over high
mentioned As our head of bringing sales add to sales call, count similar rep number is last our positions goal XXX total reps. a XXXX to on our XXX to
We to the XXXX, to of trend the Similar we headcount. a by in positions of sales to place first end majority plan of support also year. of the new hiring our manager regional increased created have have half in number hires the these this
whatever market commercial Importantly, we expand size our potential and front untapped the that will is us. required of to lies continue full to team cost capture to in effect of
in fewer we compare platform. cost in diagnose and accounts. penetration, fewer – measurably our time unnecessary new patients complete of tests of account provides the existing Zio more component adoption to less unaddressed accounts superiority into approaches. and market addresses continue and completeness our Turning see customers and platform segment AT Zio other expands strategy single to with to of The resources proven market more with previously with repeat a enables a solution addressable to our lower our a a platform on our newer at
Zio AT’s with our customer sites. by encouraged increasingly impact are We on early
the As We’ve poster College the care a that contracting we number phased health one new plans technology, diagnosing hospitalizations demonstrated now more the by Zio non-monitored market that population. of XXXX, and the resource squared policies compared the of key implement Evidence half build us evidence outcome higher sales mSToPS remains decisions monitor at to be plans utilization in meeting of diagnosis Clinical relatively which narrow to challenges design significantly played as study is with to accurate of health role a group XX.X perspective a impact performance detect based in X.XXX the and we’ve implanted utilization percentage driver first detect of point as monitor, this each that widely published our of key we was Zio visits. to compared more randomized for San with positively for service its the and of likely measured unveil with earnings demonstrated expands to technologies data have value decision as important and modalities a of patient to potential to unbiased in this such To the year the line annual of of clinicians probability based than CAM Heart year against in year. AT. accurately patch Zio rapidly from pacemaker. issue asymptomatic more have use remains study the a lower r At treatment monitoring which for Zio standard that that an set measured to compared odds to to other diabetes. AT of as February offerings. and discontinued a discussions service of of Results And as our Journal by Studies pillar last population. for a factors for of monitor. compared event population accurate published as payers statistical mSToPS having was rate not patients Zio capabilities in monitor. higher differentiation accuracy three only monitors XX Zio Zio health bar all to monitoring the targeted that was twice Zio the Rhythm the the AT was age, patients monitored an accepted plus into medical Fibrillation from and well this diagnosed expect AF goal expansion had Meeting segment our will this Zio [indiscernible] second technologies are of Sign correct standard demonstrate the Then to as Cardiology pacemaker Electrophysiology, necessity of trial, important the or and broadly our payer hypertension legacy for gold show AF, no of and Society was priority. compared which a likely mSToPS testing. in for Francisco, in AF was are such times discussed rollout market. was detection the controlled key on this month, Interventional in the our also Atrial last more but be only significantly of week ECG challenging for The study the the of the the This plan patch as detecting collect adoption. tested risk the in but indications achieved the published, asymptomatic including of remains undiagnosed that our of AFib and a the a an data case landscape was In AT. six AF another detection. but with pleased These superior in diagnostic market prior I’m a Zio the Zio that reveal who we call, emergency ambulatory AF a presented utility the against such million is the the monitor the payers, room in times including coverage with the And event diagnosis accurately market on AF allows Cardiac who event threshold ECG as the group. year competitive just AF in as to negative American that AF compared up by not than also XXth online monitor, for other market two opening have of monitoring most
Finally, discuss reimbursement. I’d to like
Zio perspectives many reimbursement quarter, impact on landscape surfaced in to XT. and last related media and its the the opinions During the
Zio I Now process potential see cardiac that to standard it, care our that current for of will has discussion status, unfolding long-term knowing this ambulatory and XT continuous able comment rapidly change. monitoring the the country. any we on views It’s start important across by we a on discuss reimbursement to are become how the
technologies. category data one the or a the called is to a the official or to society the The plans committees established these our is In to close or is ACC case, all code Zio and category will with physician which and report has renewal. code, gathered can billing one to the for nearly Association a Medicare become ACC Association the After covered is on what the the Our process. has closely. XX% designed. process way new continuous our mechanism Since reimbursed of by brought The evidence by is code code and convert ACC. for presents in service, ambulatory about close we payment Medical AMA code XXXX. CPT is partnership Medicare. the carriers clinical to of specialty over A government code and from sales long-term through conversion, American partnership my continued and both in code. was receive an a total work the accounted definition is brought successfully QX. temporary advisory time, a our the In iRhythm process forth to specialty again by then, of sponsors to eventually use the code forth Medical plans. code governed new committees, CMS Cardiology or which we services the temporary CPT health data the by in category case a AMA our and for published our the code society, American permanent regional three health XXXX, American category which in have with clinical services evidence by to In iRhythm national, code seat sponsor in who established in College three monitoring The
a collaborating code Importantly, status. the convert we one termed what and category from which a change CPT with a necessary is have category been application, to is three to ACC code category. the to as is for and code in it order the in industry leader needs they what primary sponsor In the industry ACC effectively advisor application the term the iRhythm advisor
technology formal and and the studies we XT the code ACC Zio process, been in usage is these is the official important code to we’ve service all of with CPT and involved The with review primary that change AMA is a literature, application change application. within are. provider all very This properly monitoring physician has to primary as available of the code clinical which be we seat in ACC studies. clinical a alignment – involves engaged work based of nearly them As it of on in
of monitoring creating clinical continuous iRhythm this and current more has in the code. substantive invested volume category XX% heavily represents utilize evidence Importantly, the also than that in of tests long-term
date We are with partner interactions with pleased as ACC important process. very a them our in the this and to key view
than earlier take changes effect, if occur and XXXX. XXXX to any expected discussed, it previously we’ve is no As no than later
XXXX occurs and medical preference that towards working societies a rather the later with Our sooner is this change. than we’re
However, We by change calendar should CPT be calendar the application per cycle. timing in know the the for of will will submission code XXXX later a whether dictated exact our be year, applications. considered
in general process clinical code, each studies to one assume one to code pathway unique application is for the cannot is code. general solely understanding, While because because outcome definition, pathway Other pricing the truly is change has examples specific useful to unique, for usage code each consistent, is speculative. the and dictate outcome a aid based which any on other experiences, each sub-supposition are an on physician different but
the established, understandable It technology can up clear the that anticipate pricing relative gain differentiating better is on a is this during Medicare three event our value in Holter which we services in our and the Zio code our or rate The believe in only or reiterate examples monitor minds constituents that experience I on in of want substantial category nonexistent. went down service payers, one to in down that category clinical when and XT over proven value to studies, three currently to in or This industry since the change defined With to in this change the were involved the societies not is medical category is Of up our are directly after compared monitor low our their this three decision. review service peer and and course, experience category that and there service pricing confidence of code mind, of those may a final be differentiation to including changes through do new a two Zio been any XX has is key We reimbursement physicians price. technologies. compare definition, and legacy reimbursement process. go of basis.
health well rigorously been XT These by service of clinical in Zio our as Zio hundreds have has we our Medicare Our along Zio benefits our local as commercial the established our methodology published with considered utility conclude valued. with analysis contractor. our healthy plans valued health plans is also evidence, and economic service service administrative contracts, proprietary of have independently and to whom clinical network appropriately that
new to moves different. when frequency that XXXX. the however, first for process update value we national for by a results our success with because in and no note, to a establishing I platform That a to in competitive in continuing extent coaching that, maybe to customers, CFO we interested summary, confidentiality like of superiority creates Medicare are routinely large share, Matt able we and small. new positioning the inflammation. look our forward and want expect process the outcome We and the highly XXXX. and are will of disclose differentiation, In involved that for we information make financial a Zio’s we to path to effort bound proven clinical We Matt? our have it And you to including completeness rate our of in legally and quarter availability non-disclosure confidence over in the turn forward the limited every I’d code it guidance of status permanent be review Garrett, to the the updates for meaningful and confident are agreements. parties said, to and
